$171.50–$190.41
Use 30901 for limited treatment of an anterior bleed, rather than posterior packing or cautery for a posterior source.
On this page
CMS RVU26D · Effective 2026-10-01
30905 Nosebleed control Medicare reimbursement rates in Massachusetts
Reports initial control of posterior nasal bleeding when treatment requires posterior packing, cautery, or both, such as during emergency or otolaryngology care. Compare 30905 office and facility rates across CMS payment localities in Massachusetts.
Amounts below use the non-QP conversion factor for participating physicians. These are base physician payments before claim-level adjustments, not patient costs or total hospital charges.
What does Medicare pay for 30905 in Massachusetts?
Massachusetts has 2 payment localities in this comparison. Use the service location to choose the applicable amount. These are the supported base rates for the 2 payment areas shown below, using the same CMS release.
Office / nonfacility
$410.72–$458.42
2 of 2 localities have a supported rate.
Facility setting
$98.75–$104.67
2 of 2 localities have a supported rate.
These are locality ranges, not averages or address-specific quotes. A facility-setting amount covers the physician service; it does not include a hospital’s separate bill. Choose a locality below to inspect its calculation, compare other payment areas, or price a percentage of Medicare.
ENT procedure
About 30905: Initial posterior nosebleed control
Reports initial control of posterior nasal bleeding when treatment requires posterior packing, cautery, or both, such as during emergency or otolaryngology care.
This service treats a posterior nasal bleed with posterior packing, cautery, or both. It is commonly performed by an emergency physician or otolaryngologist in an emergency department or hospital when bleeding arises from the back of the nasal cavity and needs more than limited anterior treatment. Posterior packs or balloon devices may be used to control bleeding; cautery may be used when the bleeding site can be identified.
Report 30905 for the initial control of a posterior bleed, not for a later repeat-control service. The note should support the posterior source or clinical circumstances, identify the treatment performed, and establish that this was the initial treatment. CMS assigns a 0-day global period, so same-day preoperative and postoperative care is included. When multiple procedures are performed in the same session, the highest-valued procedure is paid in full and other procedures are subject to the standard 50% multiple-procedure reduction. The code is priced as bilateral, so modifier 50 does not increase payment. Assistant-at-surgery payment is restricted; co-surgeons and team surgery are not permitted.
CMS billing rules for 30905
- Global period
- Minor procedure with a 0-day global period: same-day preoperative and postoperative care is included.
- Multiple procedures
- Standard multiple procedure reduction: the highest-valued procedure is paid in full and others at 50% when performed in the same session.
- Bilateral procedures
- The code is already priced as bilateral; modifier 50 does not increase payment.
- Assistant at surgery
- Statutory restriction: assistant at surgery is not paid.
- Co-surgeons
- Co-surgeons not permitted.
- Team surgery
- Team surgery not permitted.
Where the value comes from
- Work RVU1.92 · 16%
- Practice expense (office) RVU9.53 · 80%
- Malpractice RVU0.39 · 3%
3.6K
Medicare services in 2024 · #2060 by national volume
This summary was written with AI assistance from CMS physician fee schedule data and checked against the CMS billing rules shown here. Rates on this page come directly from CMS files.
30905 compared with similar codes
Office rates for Massachusetts, from the same CMS release.
$275.71–$306.94
30903 is for more extensive control of an anterior bleed; 30905 addresses initial control of a posterior bleed.
$422.11–$469.57
30905 reports initial posterior bleed control; 30906 reports subsequent control.
No office rate
30915 describes arterial treatment for nasal hemorrhage, a different intervention from posterior packing or cautery reported with 30905.
Compare 30905 by payment locality
Find the payment area for your service address, then open its rate page for calculation inputs, release history and the percentage-of-Medicare tool. A city may cross payment-area boundaries; the ZIP lookup above helps resolve the location.
2 of 2 payment localities
Metropolitan Boston →
Office / nonfacility
$458.42
Facility
$104.67
Rest Of Massachusetts →
Office / nonfacility
$410.72
Facility
$98.75
Need rates for a whole code list?
Fee-sheet and API access are in early access. Tell us which codes and locations your team needs.
30905 billing questions
How is 30905 different from 30901 or 30903?
30905 is for initial control of a posterior nasal bleed using posterior packing, cautery, or both. Codes 30901 and 30903 describe anterior control, with 30903 used for more extensive anterior treatment.
When should 30906 be used instead?
Use 30906 for subsequent control of a posterior bleed after the initial treatment. Use 30905 for the initial control service.
Does modifier 50 increase payment for bilateral treatment?
No. CMS prices 30905 as bilateral, and modifier 50 does not increase payment.
What documentation supports 30905?
Document the posterior bleeding source or the clinical basis for posterior treatment, the packing or cautery performed, and whether this was the initial control service.
How does the 0-day global period affect same-day care?
Same-day preoperative and postoperative care is included in the procedure. The 0-day global period does not include care on later dates.
Can an assistant or co-surgeon be reported?
CMS restricts assistant-at-surgery payment for this code and does not permit co-surgeons or team surgery.
Where these rates come from
FeeBase calculates base physician payments from CMS work, practice-expense, and malpractice RVUs, adjusted by each locality’s geographic indices and the applicable conversion factor. Unavailable or separately priced services are labeled rather than assigned a made-up amount.
Source: RVU26D. Effective 2026-10-01 through the day before 2027-01-01.
3,4783089F,,Mdd moderate,I,,0.00,0.00,,0.00,,0.00,0.00,0.00,9,XXX,0.00,0.00,0.00,9,9,9,9,9,9,,33.4009,09,0,99,0.00,0.00,0.00
3,47930901,,Control of nosebleed,A,,1.07,3.70,,0.23,,0.19,4.96,1.49,0,000,0.00,0.00,0.00,2,1,1,0,0,9,,33.4009,09,0,99,0.00,0.00,0.00
3,48030903,,Control of nosebleed,A,,1.50,6.18,,0.31,,0.28,7.96,2.09,0,000,0.00,0.00,0.00,2,1,1,0,0,9,,33.4009,09,0,99,0.00,0.00,0.00
3,48130905,,Control of nosebleed,A,,1.92,9.53,,0.66,,0.39,11.84,2.97,0,000,0.00,0.00,0.00,2,2,1,0,0,9,,33.4009,09,0,99,0.00,0.00,0.00
3,48230906,,Repeat control of nosebleed,A,,2.39,9.37,,0.75,,0.43,12.19,3.57,0,000,0.00,0.00,0.00,2,2,1,0,0,9,,33.4009,09,0,99,0.00,0.00,0.00
3,4833090F,,Mdd severe w/o psych,I,,0.00,0.00,,0.00,,0.00,0.00,0.00,9,XXX,0.00,0.00,0.00,9,9,9,9,9,9,,33.4009,09,0,99,0.00,0.00,0.00
3,48430915,,Ligation nasal sinus artery,A,,7.25,7.87,NA,7.87,,1.07,16.19,16.19,0,090,0.10,0.76,0.14,2,0,1,0,0,9,,33.4009,09,0,99,0.00,0.00,0.00